Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 100 of 100
International
Ebola outbreak’s impact on 5 key industries
By
Benjamin Snyder
October 3, 2014
International
Salix scraps inversion-based deal to buy Cosmo
By
Reuters
October 3, 2014
Finance
As Ebola spreads, drug companies race to develop treatments
By
Laura Lorenzetti
October 2, 2014
Finance
Stocks roiled by news of first American Ebola case
By
Laura Lorenzetti
October 1, 2014
Finance
J&J buys Alios BioPharma to gain access to infant medicine
By
Laura Lorenzetti
September 30, 2014
Finance
Tax inversion target companies hit by U.S. crackdown
By
Laura Lorenzetti
September 23, 2014
Finance
Merck pays $17 billion for chemical-maker Sigma-Aldrich
By
Laura Lorenzetti
September 22, 2014
Finance
Government benefits, not political pressure, convinced Walgreen to stay stateside
By
Laura Lorenzetti
September 16, 2014
Highest-paid female executive seeks immortality—digitally
By
Robert Hackett
September 12, 2014
Features
How to stop Ebola
By
Erika Fry
September 4, 2014
Retail
CVS stakes its claim in the healthcare market with new name change
By
Laura Lorenzetti
September 3, 2014
Finance
Roche paying $8.3 billion for InterMune and its ‘breakthrough’ respiratory drug
By
Laura Lorenzetti
August 25, 2014
Finance
SEC is reportedly probing the Valeant-Ackman bid for Botox-maker Allergan
By
Tom Huddleston Jr.
August 14, 2014
Management
Kathy Giusti: Cancer Warrior
By
Geoff Colvin
August 14, 2014
Finance
The biotechnology boom — it’s all about better data
By
Laura Lorenzetti
August 11, 2014
Most Popular
Success
In 2026, many employers are ditching merit-based pay bumps in favor of ‘peanut butter raises’
By
Emma Burleigh
Cybersecurity
Top AI leaders are begging people not to use Moltbook, a social media platform for AI agents: It’s a ‘disaster waiting...
By
Eva Roytburg
Politics
Meet the Palm Beach billionaire who paid $2 million for a private White House visit with Trump
By
Tristan Bove